CVS Health (CVS) Morgan Stanley 20th Annual Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Morgan Stanley 20th Annual Global Healthcare Conference summary
4 Nov, 2026Operating performance and outlook
Q2 revenue grew 11% YoY; cash flow remained robust, and EPS guidance was raised in each of the prior two quarters.
Membership grew across health product lines; 2023 outlook included 98% retention, strong national account growth and group Medicare growth.
Pharmacy services posted a strong Q2; specialty book retention was 98% across about 75% of contracts, while retail scripts grew and share gains continued each quarter since Q1 2020.
Signify and value-based care strategy
Proposed Signify acquisition supports expansion into primary care, in-home services and provider-enabled services; home visits can connect consumers to MinuteClinics and pharmacy reconciliation.
Signify’s Caravan Health platform participates in MSSP and has a documented savings track record; attributed lives are expected to exceed 700,000 in 2023.
Signify brings technology, provider network and chronic-care cost-management capabilities; leadership sees integration with MinuteClinic and other assets as a long-term value-based care model.
Combining Signify’s home activities with the retail footprint is viewed as a differentiated way to coordinate member care and support Medicare Advantage care delivery.
Consumer reach and engagement
100 million people interact through Aetna and pharmacy; 5 million visit stores daily, 85% of Americans live within 10 miles of a retail location, and digital customers total 45 million.
The breadth of digital, retail and home connections is intended to engage consumers throughout their health journey; Morning Consult ranked the brand most trusted in its industry and fifth across industries.
Latest events from CVS Health
- Separation aims to unlock standalone growth while preserving investment-grade balance sheets.CVS
8th Annual Wolfe Research Healthcare Conference - Care delivery expansion and post-deleveraging capital choices shape the forward strategy.CVS
30th Annual Credit Suisse Healthcare Conference - PBM cost controls, health plan growth and integrated care underpin the outlook.CVS
The 2016 Morgan Stanley Global Healthcare Conference - Integrated pharmacy scale supported growth and more than $5B in planned 2016 shareholder returns.CVS
The UBS 2016 Global Healthcare Conference - Integrated pharmacy and clinical programs aim to improve outcomes and reduce care costs.CVS
UBS Global Healthcare Conference 2017 - Aetna integration targets >$750M in 2020 synergies and broader medical-cost savings.CVS
JP Morgan 37th Annual Healthcare conference - Cost savings and payer partnerships support long-term growth and shareholder returns.CVS
Investor Day 2016 - A $77B Aetna deal targets integrated care and $750M in year-two synergies.CVS
M&A announcement - FY18 operating profit growth guided to 1%–4%, tempered by PBM and deal-related headwinds.CVS
Guidance